Fisher & Paykel Healthcare Corporation Limited Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited

FPH

Rankning i aktier #1344
Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes... Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes in the development, manufacturing, and marketing of a wide array of medical device products and systems. These solutions are primarily utilized for acute and chronic respiratory care, during surgical procedures, and in the treatment of obstructive sleep apnea (OSA) within both hospital and home environments. Key offerings include the Airvo 2, a humidified nasal high flow system; Optiflow, for nasal high flow therapy; and the F&P 850 System, which facilitates noninvasive and invasive ventilation. The company also provides a comprehensive range of infant respiratory products, encompassing devices for resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Its extensive hospital product portfolio features humidification equipment, breathing circuits, chambers, various masks, nasal cannulas, surgical components, and different interfaces and accessories. For homecare, Fisher & Paykel Healthcare supplies masks, CPAP devices, data management software, humidifiers, and related accessories. Established in 1934, the company is headquartered in Auckland, New Zealand.
Aktiekurs
$28.18
Marknadsvärde
$16.55B
Förändring (1 dag)
-4.74%
Förändring (1 år)
37.27%
Land
NZ
Handel Fisher & Paykel Healthcare Corporation Limited (FPH)

Kategori

Healthcare
EPS för Fisher & Paykel Healthcare Corporation Limited (FPH)
EPS per 2026 TTM: 0
Enligt Fisher & Paykel Healthcare Corporation Limiteds senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) 0. Vid slutet av 2026 hade bolaget ett EPS på 0, lika med EPS från 2026 som var 0.
EPS-historik för Fisher & Paykel Healthcare Corporation Limited från 2026 till 2026
EPS vid slutet av varje år
År EPS Ändra
Inte tillräckligt med data för de angivna datumen.
EPS för liknande företag eller konkurrenter